Everett Rand Sutherland - Jun 30, 2022 Form 4 Insider Report for Krystal Biotech, Inc. (KRYS)

Role
Director
Signature
Krish Krishnan, as attorney-in-fact for Rand Everett Sutherland
Stock symbol
KRYS
Transactions as of
Jun 30, 2022
Transactions value $
$0
Form type
4
Date filed
7/1/2022, 04:18 PM
Previous filing
Jan 31, 2022
Next filing
Jul 3, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were awarded on June 30, 2022 and vest in equal monthly tranches over a one-year period.